T. Cuisset

发表

Ticagrelor versus clopidogrel in elective percutaneous coronary intervention (ALPHEUS): a randomised, open-label, phase 3b trial

E. Vicaut, G. Rioufol, G. Lemesle, 2020, The Lancet.

Optimal duration of dual antiplatelet therapy post percutaneous coronary intervention in acute coronary syndrome.

T. Cuisset, P. Deharo, 2020, Trends in cardiovascular medicine.

Interventional cardiology 2018: the year in review.

P. Serruys, J. Fajadet, T. Cuisset, 2019, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Antithrombotic Agents: From Aspirin to DOACs in Coronary Artery Disease and in Atrial Fibrillation (Part I).

C. Granger, F. Verheugt, J. T. ten Berg, 2019, Journal of the American College of Cardiology.

Drug-eluting stents in elderly patients with coronary artery disease (SENIOR): a randomised single-blind trial

S. Cook, P. Sinnaeve, G. Helft, 2018, The Lancet.

Update on antithrombotic therapy after percutaneous coronary revascularisation

L. Mauri, F. Verheugt, T. Cuisset, 2017, The Lancet.

2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology.

Jeroen J. Bax, P. Kirchhof, P. Kolh, 2013, European heart journal.

Temporal Trends in Transcatheter Aortic Valve Replacement in France: FRANCE 2 to FRANCE TAVI.

P. Leprince, B. Iung, G. Rioufol, 2017, Journal of the American College of Cardiology.

Genetic and platelet function testing of antiplatelet therapy for percutaneous coronary intervention: the ARCTIC-GENE study

E. Vicaut, E. Belle, G. Montalescot, 2015, European Journal of Clinical Pharmacology.

High On-Treatment Platelet Reactivity as a Risk Factor for Secondary Prevention After Coronary Stent Revascularization: A Landmark Analysis of the ARCTIC Study

E. Vicaut, G. Montalescot, M. Kerneis, 2014, Circulation.

Bedside monitoring to adjust antiplatelet therapy for coronary stenting.

E. Vicaut, G. Montalescot, M. Kerneis, 2012, The New England journal of medicine.

How should I treat a significant and inoperable left main coronary atherosclerotic disease (LMCAD) in the setting of a severely depressed left ventricular systolic function and severe aorto-iliac atherosclerotic disease?

T. Cuisset, P. Deharo, P. Kahlert, 2015, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Impact of Direct Transcatheter Aortic Valve Replacement Without Balloon Aortic Valvuloplasty on Procedural and Clinical Outcomes: Insights From the FRANCE TAVI Registry.

P. Leprince, N. Jaussaud, B. Iung, 2018, JACC. Cardiovascular interventions.

Value of CMR in quantification of paravalvular aortic regurgitation after TAVI.

N. Jaussaud, T. Cuisset, J. Bonnet, 2015, European heart journal cardiovascular Imaging.

Quantitative assessment of coronary microvascular function in patients with and without epicardial atherosclerosis

G. Davidavičius, W. Wijns, T. Cuisset, 2010 .

Can CT angiography replace catheter coronary angiography?

G. Davidavičius, W. Wijns, T. Cuisset, 2010, EuroIntervention.

Platelet function monitoring to adjust antiplatelet therapy in elderly patients stented for an acute coronary syndrome (ANTARCTIC): an open-label, blinded-endpoint, randomised controlled superiority trial

E. Vicaut, E. Belle, G. Montalescot, 2016, The Lancet.

Reply: Reply

M. Alessi, T. Cuisset, J. Quilici, 2014 .

Coronary wall characteristics after myocardial infarction without significant coronary angiographic lesion: an intravascular ultrasound study

T. Cuisset, J. Bonnet, M. Lambert, 2010, Acta cardiologica.

On the inappropriateness of noninvasive multidetector computed tomography coronary angiography to trigger coronary revascularization: a comparison with invasive angiography.

W. Wijns, G. Sarno, T. Cuisset, 2009, JACC. Cardiovascular interventions.

Effect of motivational mobile phone short message service on aspirin adherence after coronary stenting for acute coronary syndrome.

P. Morange, M. Alessi, P. Carrieri, 2013, International journal of cardiology.

Potential mechanism of acute stent thrombosis with bivalirudin following percutaneous coronary intervention in acute coronary syndromes.

P. Morange, T. Cuisset, L. Bonello, 2016, International journal of cardiology.

Platelet CD40 ligand and bleeding during P2Y12 inhibitor treatment in acute coronary syndrome

M. Poggi, D. Bastelica, M. Alessi, 2019, Research and practice in thrombosis and haemostasis.

Chronic kidney disease has a significant impact on platelet inhibition of new P2Y12 inhibitors.

P. Morange, M. Alessi, G. Bonnet, 2015, International journal of cardiology.

Impact of new P2Y12 blockers on platelet reactivity and clinical outcomes after acute coronary syndrome: Insight from a large single center registry

P. Morange, M. Alessi, G. Bonnet, 2014 .

Comparison of bleeding complications and 3-year survival with low-molecular-weight heparin versus unfractionated heparin for acute myocardial infarction: the FAST-MI registry.

N. Danchin, T. Simon, J. Silvain, 2012, Archives of cardiovascular diseases.

Impact of newP 2 Y 12 blockers on platelet reactivity and clinical outcomes after acute coronary syndrome : Insight from a large single center registry

P. Morange, M. Alessi, G. Bonnet, 2014 .

CYP-Mediated Pharmacologic Interference with Optimal Platelet Inhibition

T. Cuisset, J. Quilici, 2013, Journal of Cardiovascular Translational Research.

Trial Design Principles for Patients at High Bleeding Risk Undergoing PCI: JACC Scientific Expert Panel.

Deepak L. Bhatt, Sunil V. Rao, S. Pocock, 2020, Journal of the American College of Cardiology.

A new approach: Left atrial appendage occlusion, as an alternative to anticoagulant, to treat patient who suffered of atrial fibrillation, acute coronary syndrome and clopidogrel resistance.

T. Cuisset, J. Bonnet, M. Pankert, 2016, International journal of cardiology.

Prosthesis-patient mismatch is an independent predictor of congestive heart failure after transcatheter aortic valve replacement.

N. Jaussaud, T. Cuisset, P. Deharo, 2021, Archives of cardiovascular diseases.

Rapid deployment versus trans‐catheter aortic valve replacement in intermediate‐risk patients: A propensity score analysis

N. Jaussaud, T. Cuisset, P. Deharo, 2021, Journal of cardiac surgery.

Impact of Sapien 3 Balloon-Expandable Versus Evolut R Self-Expandable Transcatheter Aortic Valve Implantation in Patients With Aortic Stenosis

L. Fauchier, T. Cuisset, P. Deharo, 2019, Circulation.

Patient-prosthesis mismatch in new generation trans-catheter heart valves: a propensity score analysis

N. Jaussaud, T. Cuisset, G. Habib, 2018, European heart journal cardiovascular Imaging.

Fractional flow reserve--the influence of the collateral circulation.

T. Cuisset, B. De Bruyne, M. Hamilos, 2009, International journal of cardiology.

Cost-Effectiveness of Drug-Eluting Stents in Elderly Patients With Coronary Artery Disease: The SENIOR Trial.

S. Cook, I. Durand-zaleski, P. Sinnaeve, 2019, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

Monitoring platelet function: what have we learned from randomized clinical trials?

T. Cuisset, P. Deharo, 2018, Cardiovascular diagnosis and therapy.

Optimal P2Y12 Inhibitor for Primary Percutaneous Coronary Intervention in ST-Segment Elevation Myocardial Infarction: Network Meta-Analysis in the Data-Free Zone: Do You Believe in Magic?

W. Wijns, D. Capodanno, T. Cuisset, 2016, JACC. Cardiovascular interventions.

Is platelet inhibition correlated with time from last intake on P2Y12 blockers after an acute coronary syndrome? A pilot study

P. Morange, M. Alessi, G. Bonnet, 2016, Platelets.

Prasugrel Use in Real Life: A Report From the Outpatient Setting in France

T. Cuisset, P. Sabouret, M. Taiel-Sartral, 2016, Clinical cardiology.

Bleeding and stent thrombosis on P2Y12-inhibitors: collaborative analysis on the role of platelet reactivity for risk stratification after percutaneous coronary intervention.

M. Price, G. Stone, A. Kirtane, 2015, European heart journal.

Usefulness of Routine Fractional Flow Reserve for Clinical Management of Coronary Artery Disease in Patients With Diabetes.

S. Porouchani, J. Dallongeville, C. Pouillot, 2020, JAMA cardiology.

Two‐year outcomes after percutaneous coronary intervention with drug‐eluting stents or bare‐metal stents in elderly patients with coronary artery disease

S. Cook, P. Sinnaeve, G. Helft, 2020, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Blood transfusion and ischaemic outcomes according to anemia and bleeding in patients with non-ST-segment elevation acute coronary syndromes: Insights from the TAO randomized clinical trial.

J. Jukema, S. Mehta, C. Bode, 2020, International journal of cardiology.

BleedingandstentthrombosisonP 2 Y 12-inhibitors : collaborative analysis on the role of platelet reactivity for risk stratification after percutaneous coronary intervention

M. Price, G. Stone, A. Kirtane, 2015 .

Systematic detection of polyvascular disease combined with aggressive secondary prevention in patients presenting with severe coronary artery disease: The randomized AMERICA Study.

E. Vicaut, G. Montalescot, J. Collet, 2018, International journal of cardiology.

Initial experience with the WATCHMAN™ left atrial appendage system for stroke prevention in atrial fibrillation: A single-centre registry.

G. Bonnet, T. Cuisset, J. Bonnet, 2016, Archives of cardiovascular diseases.

Unusual cause of hypoxemia in myocardial infarction: interventional management.

T. Cuisset, J. Bonnet, M. Pankert, 2014, International Journal of Cardiology.

Relationship between aspirin and clopidogrel responses in acute coronary syndrome and clinical predictors of non response.

P. Morange, M. Alessi, T. Cuisset, 2009, Thrombosis research.

Valve‐in‐valve transcatheter aortic valve replacement or re‐surgical aortic valve replacement in degenerated bioprostheses: A systematic review and meta‐analysis of short and midterm results

L. Fauchier, F. D’Ascenzo, T. Cuisset, 2022, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Early versus delayed invasive strategy for intermediate‐ and high‐risk acute coronary syndromes managed without P2Y12 receptor inhibitor pretreatment: Design and rationale of the EARLY randomized trial

K. Baumstarck, G. Lemesle, Z. Boueri, 2018, Clinical cardiology.

De-Escalation of Dual Antiplatelet Therapy in Patients With Acute Coronary Syndromes.

S. Kohsaka, T. Kuno, Tomohiro Fujisaki, 2021, Journal of the American College of Cardiology.

Assessment of epicardial fat volume and myocardial triglyceride content in severely obese subjects: relationship to metabolic profile, cardiac function and visceral fat

K. Clément, P. Morange, M. Alessi, 2012, International Journal of Obesity.

CYP2C19*2 and *17 alleles have a significant impact on platelet response and bleeding risk in patients treated with prasugrel after acute coronary syndrome.

P. Morange, M. Alessi, T. Cuisset, 2012, JACC. Cardiovascular interventions.

Use of invasive strategy in non-ST-segment elevation myocardial infarction is a major determinant of improved long-term survival: FAST-MI (French Registry of Acute Coronary Syndrome).

J. Ferrières, G. Lemesle, N. Danchin, 2012, JACC. Cardiovascular interventions.

Benefit of switching dual antiplatelet therapy after acute coronary syndrome: the TOPIC (timing of platelet inhibition after acute coronary syndrome) randomized study

P. Morange, M. Alessi, G. Bonnet, 2017, European heart journal.

Lack of effect of chronic kidney disease on clopidogrel response with high loading and maintenance doses of clopidogrel after Acute Coronary Syndrome.

P. Morange, M. Alessi, T. Cuisset, 2010, Thrombosis research.

On-Ticagrelor Platelet Reactivity and Clinical Outcome in Patients Undergoing Percutaneous Coronary Intervention for Acute Coronary Syndrome

G. Lemesle, M. Alessi, T. Cuisset, 2020, Thrombosis and Haemostasis.

Timing of Angiography and Outcomes in High-Risk Patients With Non–ST-Segment–Elevation Myocardial Infarction Managed Invasively: Insights From the TAO Trial (Treatment of Acute Coronary Syndrome With Otamixaban)

M. Sabatine, S. Mehta, C. Bode, 2017, Circulation.

Rationale and use of antiplatelet and antithrombotic drugs during cardiovascular interventions: May 2010 update.

M. Valgimigli, K. Huber, H. Mudra, 2008, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Rationale and use of antiplatelet and antithrombotic drugs during cardiovascular interventions: May 2010 update

M. Valgimigli, K. Huber, H. Mudra, 2010 .

Multicenter Fractional Flow Reserve Registry Flow Reserve at Time of Diagnostic Angiography : Insights From a Large French Outcome Impact of Coronary Revascularization Strategy Reclassification With Fractional

G. Rioufol, J. Dallongeville, E. Belle, 2013 .

Valve-in-valve transcatheter aortic valve implantation after failed surgically implanted aortic bioprosthesis versus native transcatheter aortic valve implantation for aortic stenosis: Data from a nationwide analysis.

L. Fauchier, N. Jaussaud, T. Cuisset, 2020, Archives of cardiovascular diseases.

Contents

L. Fauchier, T. Cuisset, P. Deharo, 2020, Journal of the American College of Cardiology.

Impact of obesity and the metabolic syndrome on response to clopidogrel or prasugrel and bleeding risk in patients treated after coronary stenting.

A. Loundou, P. Morange, M. Alessi, 2014, The American journal of cardiology.

Myocardial Revascularization Strategies in ST Elevation Myocardial Infarction Without Urgent Revascularization: Insight From a Nationwide Study.

L. Fauchier, N. Jaussaud, T. Cuisset, 2022, Mayo Clinic proceedings.

Platelet reactivity and cardiovascular events after percutaneous coronary intervention in patients with stable coronary artery disease: the Stent Thrombosis In Belgium (STIB) trial.

W. Wijns, E. Barbato, T. Cuisset, 2014, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Paraoxonase-1 and clopidogrel efficacy

P. Morange, M. Alessi, T. Cuisset, 2011, Nature Medicine.

Clopidogrel resistance: what's new?

J. Silvain, G. Cayla, T. Cuisset, 2010, Archives of cardiovascular diseases.

Comparison of omeprazole and pantoprazole influence on a high 150-mg clopidogrel maintenance dose the PACA (Proton Pump Inhibitors And Clopidogrel Association) prospective randomized study.

P. Morange, M. Alessi, T. Cuisset, 2009, Journal of the American College of Cardiology.

Prasugrel monitoring and bleeding in real world patients.

P. Morange, G. Montalescot, M. Kerneis, 2013, The American journal of cardiology.

Effect of CYP2C19*2 and *17 genetic variants on platelet response to clopidogrel and prasugrel maintenance dose and relation to bleeding complications.

W. Cohen, P. Morange, M. Alessi, 2013, The American journal of cardiology.

High prevalence of mutations in perilipin 1 in patients with precocious acute coronary syndrome.

A. Loundou, P. Morange, A. Blanchard, 2019, Atherosclerosis.

International Expert Consensus on Switching Platelet P2Y12 Receptor–Inhibiting Therapies

Deepak L. Bhatt, M. Price, R. Mehran, 2017, Circulation.

Usefulness of high clopidogrel maintenance dose according to CYP2C19 genotypes in clopidogrel low responders undergoing coronary stenting for non ST elevation acute coronary syndrome.

W. Cohen, P. Morange, M. Alessi, 2011, The American journal of cardiology.

Post-PCI fatal bleeding in aspirin and clopidogrel hyper responder: shifting from antiplatelet resistance to bleeding risk assessment?

M. Alessi, T. Cuisset, J. Bonnet, 2010, International journal of cardiology.

Predictive value of post-treatment platelet reactivity for occurrence of post-discharge bleeding after non-ST elevation acute coronary syndrome. Shifting from antiplatelet resistance to bleeding risk assessment?

P. Morange, M. Alessi, G. Cayla, 2009, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Effects of Bariatric Surgery on Cardiac Ectopic Fat

K. Clément, M. Alessi, T. Cuisset, 2012 .

Effects of bariatric surgery on cardiac ectopic fat: lesser decrease in epicardial fat compared to visceral fat loss and no change in myocardial triglyceride content.

K. Clément, M. Alessi, T. Cuisset, 2012, Journal of the American College of Cardiology.

Fractional flow reserve: concepts, applications and use in France in 2010.

O. Muller, M. Gilard, T. Cuisset, 2010, Archives of cardiovascular diseases.

Index of Microcirculatory Resistance: a new effective invasive tool to assess reperfusion after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction.

T. Cuisset, J. Bonnet, J. Quilici, 2011, International journal of cardiology.

Multivessel PCI in STEMI: ready to be the recommended strategy?

M. Noc, T. Cuisset, 2014, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Epicardial Fat Volume Is Associated With Coronary Microvascular Response in Healthy Subjects: A Pilot Study

K. Clément, P. Cozzone, M. Alessi, 2012, Obesity.

Three‐Dimensional Transesophageal Echocardiography Assessment of a Successful Transcatheter Mitral Valve in Valve Implantation for Degenerated Bioprosthesis

N. Jaussaud, J. Aviérinos, T. Cuisset, 2013, Echocardiography.

Will this trial change my practice? ACCOAST - early loading with a novel P2Y12 inhibitor in patients with an acute coronary syndrome.

P. Jüni, S. James, T. Cuisset, 2014, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Clinical implications of very low on-treatment platelet reactivity in patients treated with thienopyridine: the POBA study (predictor of bleedings with antiplatelet drugs).

A. Loundou, P. Morange, M. Alessi, 2013, JACC: Cardiovascular Interventions.

Comparison between initial and chronic response to clopidogrel therapy after coronary stenting for acute coronary syndrome and influence on clinical outcomes.

P. Morange, M. Alessi, T. Cuisset, 2012, American heart journal.

Comparison of platelet reactivity and clopidogrel response in patients ≤ 75 Years Versus > 75 years undergoing percutaneous coronary intervention for non-ST-segment elevation acute coronary syndrome.

P. Morange, M. Alessi, T. Cuisset, 2011, The American journal of cardiology.

Relationship between peripheral arterial reactive hyperemia and residual platelet reactivity after 600 mg clopidogrel

O. Muller, W. Wijns, G. Sarno, 2011, Journal of Thrombosis and Thrombolysis.

Adrenergic receptor polymorphisms and platelet reactivity after treatment with dual antiplatelet therapy with aspirin and clopidogrel in acute coronary syndrome

K. Verhamme, M. Alessi, W. Wijns, 2010, Thrombosis and Haemostasis.

Comparison of rosuvastatin and atorvastatin on clopidogrel response and lipidic and inflammatory parameters after coronary stenting for acute coronary syndrome: the prospective, randomized OSCAR study (optimal statin therapy with clopidogrel after coronary revascularisation).

P. Morange, M. Alessi, T. Cuisset, 2010, Thrombosis research.

Effect of increased aspirin dose after stenting in association with ClOpidogrel: the FIASCO randomized study.

P. Morange, T. Cuisset, J. Bonnet, 2009, Thrombosis research.

Aspirin noncompliance is the major cause of "aspirin resistance" in patients undergoing coronary stenting.

P. Morange, M. Alessi, T. Cuisset, 2009, American heart journal.

ADP-induced platelet aggregation and platelet reactivity index VASP are good predictive markers for clinical outcomes in non-ST elevation acute coronary syndrome

P. Morange, M. Alessi, T. Cuisset, 2007, Thrombosis and Haemostasis.

Current management and screening of peripheral and coronary artery disease in people with diabetes mellitus in Europe. The PADDIA/CADDIA survey.

N. Sattar, G. Mahé, P. Valensi, 2022, Diabetes research and clinical practice.

Prasugrel versus ticagrelor in acute coronary syndrome: a randomized comparison.

P. Morange, M. Alessi, G. Bonnet, 2013, International journal of cardiology.

Effectiveness of switching 'hyper responders' from Prasugrel to Clopidogrel after acute coronary syndrome: the POBA (Predictor of Bleeding with Antiplatelet drugs) SWITCH study.

P. Morange, M. Alessi, G. Bonnet, 2013, International journal of cardiology.

Predictors of long-term high on-treatment platelet reactivity in clopidogrel-treated patients undergoing coronary stenting for acute coronary syndrome.

P. Morange, M. Alessi, T. Cuisset, 2013, International journal of cardiology.

Clopidogrel response: head-to-head comparison of different platelet assays to identify clopidogrel non responder patients after coronary stenting.

P. Morange, M. Alessi, T. Cuisset, 2010, Archives of cardiovascular diseases.

Diagnosis of Infective Endocarditis After TAVR: Value of a Multimodality Imaging Approach.

D. Raoult, H. Lepidi, N. Jaussaud, 2018, JACC. Cardiovascular imaging.

High Post-Procedural Transvalvular Gradient or Delayed Mean Gradient Increase after Transcatheter Aortic Valve Implantation: Incidence, Prognosis and Associated Variables. The FRANCE-2 Registry

P. Leprince, B. Iung, J. Fajadet, 2021, Journal of clinical medicine.

Five-Year Clinical Outcome and Valve Durability After Transcatheter Aortic Valve Replacement in High-Risk Patients: FRANCE-2 Registry

P. Leprince, B. Iung, G. Rioufol, 2018, Circulation.

Management of two major complications in the cardiac catheterisation laboratory: the no-reflow phenomenon and coronary perforations.

S. Windecker, J. Fajadet, O. Muller, 2008, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

The CHOICE Randomized Clinical Trial.

L. Fauchier, T. Cuisset, P. Deharo, 2020, JACC. Cardiovascular interventions.

Benefit of Switching Dual Antiplatelet Therapy After Acute Coronary Syndrome According to On-Treatment Platelet Reactivity: The TOPIC-VASP Pre-Specified Analysis of the TOPIC Randomized Study.

P. Morange, M. Alessi, G. Bonnet, 2017, JACC. Cardiovascular interventions.

Trials of antithrombotic therapy in percutaneous coronary intervention: what evidence do we need to optimise our practice?

D. Capodanno, T. Cuisset, 2018, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

A037 Impact of the CYP2C19*17 allele on platelet response to clopidogrel in patients suffering from non–st elevation acute coronary syndrome

P. Morange, J. Hulot, M. Alessi, 2009 .

A 037 IMPACT OF THE CYP 2 C 19 * 17 ALLELE ON PLATELET RESPONSE TO CLOPIDOGREL IN PATIENTS SUFFERING FROM NON — ST ELEVATION ACUTE CORONARY SYNDROME

P. Morange, J. Hulot, M. Alessi, 2009 .

Updated Expert Consensus Statement on Platelet Function and Genetic Testing for Guiding P2Y12 Receptor Inhibitor Treatment in Percutaneous Coronary Intervention.

Marco Valgimigli, Gregg W Stone, Matthew J Price, 2019, JACC. Cardiovascular interventions.

Non adherence to thienopyridine after coronary stenting.

P. Carrieri, T. Cuisset, L. Fugon, 2011, The American journal of cardiology.

Bene ﬁ t of Switching Dual Antiplatelet Therapy After Acute Coronary Syndrome According to On-Treatment Platelet Reactivity

P. Morange, M. Alessi, G. Bonnet, 2017 .

Femoral Versus Nonfemoral Peripheral Access for Transcatheter Aortic Valve Replacement.

É. Marijon, P. Leprince, B. Iung, 2019, Journal of the American College of Cardiology.

Percutaneous closure of a poorly tolerated post-transcatheter aortic valve implantation ventricular septal defect.

T. Cuisset, P. Aldebert, A. Fraisse, 2014, The Annals of thoracic surgery.

Antithrombotic Therapy after Percutaneous Coronary Intervention of Bifurcation Lesions.

F. Burzotta, G. Dangas, R. Mehran, 2020, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes.

Marco Valgimigli, Jeroen J. Bax, William Wijns, 2019, European heart journal.

Intolerance to aspirin in patients undergoing percutaneous coronary intervention in the setting of chronic coronary syndromes: perspectives from the ESC 2019 Chronic Coronary Syndromes guidelines.

J. Knuuti, M. Valgimigli, W. Wijns, 2019, European heart journal.

High post-treatment platelet reactivity is associated with a high incidence of myonecrosis after stenting for non-ST elevation acute coronary syndromes

P. Morange, M. Alessi, T. Cuisset, 2007, Thrombosis and Haemostasis.

Homocysteine concentration and adenosine A2A receptor production by peripheral blood mononuclear cells in coronary artery disease patients

R. Guieu, T. Cuisset, P. Deharo, 2020, Journal of cellular and molecular medicine.

Reasons for the Failure of Platelet Function Testing to Adjust Antiplatelet Therapy: Pharmacodynamic Insights From the ARCTIC Study.

E. Vicaut, G. Montalescot, J. Collet, 2019, Circulation. Cardiovascular interventions.

Platelet reactivity inhibition following ticagrelor loading dose in patients undergoing percutaneous coronary intervention for acute coronary syndrome

M. Alessi, T. Cuisset, L. Bonello, 2019, Journal of thrombosis and haemostasis : JTH.

High residual platelet reactivity and thrombotic events.

P. Morange, M. Alessi, T. Cuisset, 2011, JAMA.

Comparison of Unguided De-Escalation Versus Guided Selection of Dual Antiplatelet Therapy After Acute Coronary Syndrome: A Systematic Review and Network Meta-Analysis

Deepak L. Bhatt, S. Kohsaka, T. Kuno, 2022, Circulation. Cardiovascular interventions.

Usefulness of index of microcirculatory resistance to detect microvascular dysfunction as a potential mechanism of stress-induced cardiomyopathy (Tako-tsubo syndrome).

T. Cuisset, J. Bonnet, M. Pankert, 2011, International journal of cardiology.

TAVR Patients Requiring Anticoagulation: Direct Oral Anticoagulant or Vitamin K Antagonist?

B. Iung, L. Labrousse, G. Rioufol, 2021, JACC. Cardiovascular interventions.

Body mass index has no impact on platelet inhibition induced by ticagrelor after acute coronary syndrome, conversely to prasugrel.

P. Morange, M. Alessi, G. Bonnet, 2014, International journal of cardiology.

Early Endocarditis and Delayed Left Ventricular Pseudoaneurysm Complicating a Transapical Transcatheter Mitral Valve-in-Valve Implantation: Percutaneous Closure Under Local Anesthesia and Echocardiographic Guidance.

D. Raoult, N. Jaussaud, J. Aviérinos, 2016, Circulation. Cardiovascular interventions.

Re-intervention for failed surgical aortic bioprosthesis: Remaining questions on long term outcomes and selection of patients.

L. Fauchier, T. Cuisset, P. Deharo, 2020, International journal of cardiology.

Prosthesis–Patient Mismatch in Small Aortic Annuli: Self-Expandable vs. Balloon-Expandable Transcatheter Aortic Valve Replacement

N. Jaussaud, T. Cuisset, P. Deharo, 2022, Journal of clinical medicine.

Predictive values of post-treatment adenosine diphosphate-induced aggregation and vasodilator-stimulated phosphoprotein index for stent thrombosis after acute coronary syndrome in clopidogrel-treated patients.

P. Morange, M. Alessi, T. Cuisset, 2009, The American journal of cardiology.

Fixed-dose aspirin-clopidogrel combination enhances compliance to aspirin after acute coronary syndrome.

P. Morange, M. Alessi, G. Bonnet, 2014, International journal of cardiology.

IMPACT OF PLATELET REACTIVITY ON CLINICAL OUTCOMES: A PATIENT LEVEL META-ANALYSIS

M. Price, G. Dangas, G. Patti, 2010 .

Effectiveness of switching 'low responders' to prasugrel to ticagrelor after acute coronary syndrome.

P. Morange, M. Alessi, G. Bonnet, 2014, International Journal of Cardiology.

TCT-747 Efficacy and safety of intensified antiplatelet therapy on the basis of platelet reactivity testing in patients after percutaneous coronary intervention: Systematic review and meta-analysis

M. Price, M. Valgimigli, D. Sibbing, 2012 .

Rotational atherectomy through a coronary artery bypass graft after transcatheter aortic valve implantation: a case report

T. Cuisset, P. Deharo, J. Spychaj, 2020, European heart journal. Case reports.

Reply: P2Y12-Based platelet function assays should be complemented with cyclooxygenase-dependent testing in framing the therapeutic windows for dual antiplatelet therapy.

M. Alessi, T. Cuisset, J. Bonnet, 2014, JACC. Cardiovascular interventions.

Reply Reply : P 2 Y 12-Based Platelet Function Assays Should be Complemented With Cyclooxygenase-Dependent Testing in Framing the Therapeutic Windows for Dual Antiplatelet Therapy

M. Alessi, T. Cuisset, J. Bonnet, 2014 .

Transradial approach and subclavian wired temporary pacemaker to increase safety of alcohol septal ablation for treatment of obstructive hypertrophic cardiomyopathy: the TRASA trial.

T. Cuisset, J. Bonnet, M. Pankert, 2011, Archives of cardiovascular diseases.

Will this trial change my practice? The Dual Antiplatelet Therapy (DAPT) study - 12 or 30 months of dual antiplatelet therapy after drug-eluting stents.

A. Baumbach, A. Lansky, A. Gershlick, 2015, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Contemporary techniques for catheter-based intervention for hypertrophic obstructive cardiomyopathy.

T. Cuisset, T. Lefévre, 2016, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Delayed occurrence of complete heart block after ethanol septal ablation for hypertrophic obstructive cardiomyopathy.

T. Cuisset, J. Bonnet, G. Habib, 2011, International journal of cardiology.

Lack of association between the 807 C/T polymorphism of glycoprotein Ia gene and post-treatment platelet reactivity after aspirin and clopidogrel in patients with acute coronary syndrome

P. Morange, M. Alessi, T. Cuisset, 2007, Thrombosis and Haemostasis.

A case of false positive cardiac troponin I in CANOMAD syndrome.

R. Guieu, T. Cuisset, S. Attarian, 2016, International journal of cardiology.

Subclavicular screwed wire transient pacing to increase safety of transcatheter aortic valve implantation with the CoreValve system.

T. Cuisset, J. Quilici, 2011, Journal of cardiology cases.

Long-Term Prognosis Value of Paravalvular Leak and Patient–Prosthesis Mismatch following Transcatheter Aortic Valve Implantation: Insight from the France-TAVI Registry

N. Jaussaud, B. Iung, J. Collet, 2022, Journal of clinical medicine.

[Endomyocardial fibrosis: a rare case of restrictive cardiomyopathy in a Caucasian female].

T. Cuisset, J. Bonnet, O. Ghez, 2006, Archives des maladies du coeur et des vaisseaux.

Outcome Impact of Coronary Revascularization Strategy Reclassification With Fractional Flow Reserve at Time of Diagnostic Angiography: Insights From a Large French Multicenter Fractional Flow Reserve Registry

G. Rioufol, J. Dallongeville, C. Pouillot, 2014, Circulation.

Enhanced post‐clopidogrel platelet reactivity in diabetic patients is independently related to plasma fibrinogen level but not to glycemic control

M. Alessi, T. Cuisset, C. Frère, 2009, Journal of thrombosis and haemostasis : JTH.

A prospective randomized evaluation of the TriGuard™ HDH embolic DEFLECTion device during transcatheter aortic valve implantation: results from the DEFLECT III trial.

A. Brickman, A. Baumbach, P. Stella, 2015, European heart journal.

ESC guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 2—care pathways, treatment, and follow-up

G. Hindricks, D. Andreini, T. Potpara, 2021, Cardiovascular research.

ESC guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 2—care pathways, treatment, and follow-up

G. Hindricks, D. Andreini, T. Potpara, 2021, European heart journal.

Pharmacological profile of adenosine A2A receptors in patients with lower extremity peripheral artery disease and associated coronary artery disease: A pilot study.

R. Guieu, T. Cuisset, P. Deharo, 2019, International journal of cardiology.

Consensus and future directions on the definition of high on-treatment platelet reactivity to adenosine diphosphate.

Deepak L. Bhatt, M. Price, R. Becker, 2010, Journal of the American College of Cardiology.

European Society of Cardiology guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 1—epidemiology, pathophysiology, and diagnosis

G. Hindricks, D. Andreini, T. Potpara, 2021, European heart journal.

Relation of low response to clopidogrel assessed with point-of-care assay to periprocedural myonecrosis in patients undergoing elective coronary stenting for stable angina pectoris.

W. Wijns, G. Sarno, E. Barbato, 2008, The American journal of cardiology.

FFR guided PCI in a patient with dextrocardia and multivessel coronary artery disease.

T. Cuisset, G. Heyndrickx, M. Hamilos, 2008, International journal of cardiology.

Vascular risk levels affect the predictive value of platelet reactivity for the occurrence of MACE in patients on clopidogrel

A. Gori, F. Neumann, C. Combescure, 2015, Thrombosis and Haemostasis.

European Society of Cardiology guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 1—epidemiology, pathophysiology, and diagnosis

G. Hindricks, D. Andreini, T. Potpara, 2021, Cardiovascular research.

Management of anomalous origin of the left coronary artery from the pulmonary artery in an adult with ischemic cardiomyopathy and pulmonary hypertension.

T. Cuisset, L. Macé, A. Fraisse, 2014, The Annals of thoracic surgery.

Management of Antithrombotic Therapy in Atrial Fibrillation Patients Presenting with Acute Coronary Syndrome and/or Undergoing Percutaneous Coronary Intervention/ Stenting

P. Kirchhof, G. Lip, K. Huber, 2009, Thrombosis and Haemostasis.

Antithrombotic therapy in patients with atrial fibrillation undergoing coronary stenting: Similarities and dissimilarities between North America and Europe

G. Lip, K. Huber, T. Cuisset, 2011, Thrombosis and Haemostasis.

Antithrombotic management of atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing coronary stenting: executive summary--a Consensus Document of the European Society of Cardiology Working Group on Thrombosis, endorsed by the European Heart Rhythm Association (EHRA) a

P. Kirchhof, G. Lip, J. Airaksinen, 2010, European heart journal.

Index of microvascular resistance: a new effective tool to explore microvascular disease correlated with myocardial ischemia in diabetic patients without significant coronary artery disease.

T. Cuisset, J. Bonnet, A. Dutour, 2013, International journal of cardiology.

Defining high bleeding risk in patients undergoing percutaneous coronary intervention: a consensus document from the Academic Research Consortium for High Bleeding Risk

M. Price, S. Pocock, N. Stockbridge, 2019, European heart journal.

Defining High Bleeding Risk in Patients Undergoing Percutaneous Coronary Intervention

M. Price, S. Pocock, N. Stockbridge, 2019, Circulation.

Prognostic value of ischaemia-modified albumin in patients with non-ST-segment elevation acute coronary syndromes.

R. Guieu, T. Cuisset, J. Bonnet, 2008, Archives of cardiovascular diseases.

Benefit of a 600-mg loading dose of clopidogrel on platelet reactivity and clinical outcomes in patients with non-ST-segment elevation acute coronary syndrome undergoing coronary stenting.

P. Morange, M. Alessi, T. Cuisset, 2006, Journal of the American College of Cardiology.

High post‐treatment platelet reactivity identified low‐responders to dual antiplatelet therapy at increased risk of recurrent cardiovascular events after stenting for acute coronary syndrome

P. Morange, M. Alessi, T. Cuisset, 2006, Journal of thrombosis and haemostasis : JTH.

Duration of Antiplatelet Therapy After Complex Percutaneous Coronary Intervention In Patients at High Bleeding Risk: a MASTER DAPT trial sub-analysis.

M. Valgimigli, P. Smits, D. Heg, 2022, European heart journal.

Giant coronary artery aneurysm in Behçet’s disease

T. Cuisset, J. Bonnet, J. Quilici, 2007, Heart.

Impact of platelet reactivity on clinical outcomes after percutaneous coronary intervention. A collaborative meta-analysis of individual participant data.

M. Price, G. Dangas, M. Valgimigli, 2011, Journal of the American College of Cardiology.

Synergy between pharmacological and mechanical reperfusion in ST-segment elevation myocardial infarction patients: 2011 update

T. Cuisset, M. Pankert, J. Quilici, 2011, Journal of cardiovascular medicine.

Glycoprotein IIb/IIIa inhibitors improve outcome after coronary stenting in clopidogrel nonresponders: a prospective, randomized study.

P. Morange, M. Alessi, T. Cuisset, 2008, JACC. Cardiovascular interventions.

Effect of cytochrome p450 polymorphisms on platelet reactivity after treatment with clopidogrel in acute coronary syndrome.

P. Morange, M. Alessi, T. Cuisset, 2008, The American journal of cardiology.

Efficacy and safety of intensified antiplatelet therapy on the basis of platelet reactivity testing in patients after percutaneous coronary intervention: systematic review and meta-analysis.

M. Price, M. Valgimigli, D. Sibbing, 2013, International journal of cardiology.

Role of Antiplatelet Therapy in Secondary Prevention of Acute Coronary Syndrome

T. Cuisset, M. Pankert, J. Quilici, 2012, Journal of Cardiovascular Translational Research.

Bleeding in the Elderly: Risk Factors and Impact on Clinical Outcomes After an Acute Coronary Syndrome, a Sub-study of the Randomized ANTARCTIC Trial

E. Vicaut, G. Montalescot, M. Kerneis, 2021, American Journal of Cardiovascular Drugs.

[Coronary thrombosis with normal epicardial coronary arteries].

L. Chiche, T. Cuisset, L. Fourcade, 2011, Presse medicale.

Platelet P2Y12 Inhibitor Monotherapy after Percutaneous Coronary Intervention: An Emerging Option for Antiplatelet Therapy De-escalation

K. Huber, J. Collet, F. Verheugt, 2022, Thrombosis and Haemostasis.

Meta-analysis appraising high clopidogrel loading in patients undergoing percutaneous coronary intervention.

G. Biondi-Zoccai, M. Valgimigli, G. Trevi, 2007, The American journal of cardiology.

Mononuclear cell adenosine deaminase and CD26/dipeptidylpeptidase-IV activities are sensitive markers of reperfusion during percutaneous transluminal angioplasty.

R. Guieu, Y. Jammes, T. Cuisset, 2013, International journal of cardiology.

Role of the T744C polymorphism of the P2Y12 gene on platelet response to a 600-mg loading dose of clopidogrel in 597 patients with non-ST-segment elevation acute coronary syndrome.

P. Morange, M. Alessi, T. Cuisset, 2007, Thrombosis research.

Clinical Outcome of First‐ vs Second‐Generation DES According to DAPT Duration: Results of ARCTIC‐Generation

E. Vicaut, E. Belle, G. Montalescot, 2016, Clinical cardiology.

Corrigendum to: ‘2013 ESC guidelines on the management of stable coronary artery disease’

Nikolaus Marx, Roxy Senior, Manel Sabaté, 2014 .

Dual-antiplatelet treatment beyond 1 year after drug-eluting stent implantation (ARCTIC-Interruption): a randomised trial

E. Vicaut, E. Belle, G. Montalescot, 2014, The Lancet.

Platelet reactivity in diabetic patients undergoing coronary stenting for acute coronary syndrome treated with clopidogrel loading dose followed by prasugrel maintenance therapy.

A. Loundou, P. Morange, M. Alessi, 2013, International journal of cardiology.

Advantages and disadvantages of drug challenge during electrophysiological study in patients with new left bundle branch block after transaortic valve implantation

J. Deharo, T. Cuisset, P. Deharo, 2022, International journal of cardiology. Heart & vasculature.

Genetic determined low response to thienopyridines is associated with higher systemic inflammation in smokers.

G. Siest, P. Morange, M. Stathopoulou, 2015, Pharmacogenomics.

Feasibility of Non-Invasive Coronary Artery Disease Screening with Coronary CT Angiography before Transcatheter Aortic Valve Implantation

N. Jaussaud, T. Cuisset, P. Deharo, 2023, Journal of clinical medicine.

Long-Term Clinical Outcome After Fractional Flow Reserve–Guided Treatment in Patients With Angiographically Equivocal Left Main Coronary Artery Stenosis

M. Vanderheyden, O. Muller, O. Muller, 2009, Circulation.

High Radiation Exposure of the Imaging Specialist During Structural Heart Interventions With Echocardiographic Guidance.

N. Jaussaud, J. Deharo, T. Cuisset, 2017, JACC. Cardiovascular interventions.

Background—Individualizing antiplatelet therapy after platelet function testing did not improve outcome after coronary stenting in the Assessment by a Double Randomization of a Conventional Antiplatelet Strategy Versus a Monitoring- Guided Strategy for Drug-Eluting Stent Implantation and of Treatmen

E. Vicaut, E. Belle, G. Montalescot, 2014 .

Off-label use of prasugrel in stable coronary artery disease is associated with greater degree of platelet inhibition compared with use after acute coronary syndrome.

P. Morange, M. Alessi, G. Bonnet, 2013, International journal of cardiology.

Recent advances in the pharmacogenetics of clopidogrel

P. Morange, M. Alessi, T. Cuisset, 2012, Human Genetics.

Platelet function monitoring in elderly patients on prasugrel after stenting for an acute coronary syndrome: design of the randomized antarctic study.

E. Vicaut, G. Montalescot, J. Collet, 2014, American heart journal.

Balloon-Expandable Versus Self-Expanding Transcatheter Aortic Valve Replacement

P. Leprince, B. Iung, G. Rioufol, 2019, Circulation.

Contribution of exome sequencing to the identification of genes involved in the response to clopidogrel in cardiovascular patients

Brian J. Stevenson, I. Xenarios, Y. Daali, 2020, Journal of thrombosis and haemostasis : JTH.

Reduced Mortality With Antiplatelet Therapy Deescalation After Percutaneous Coronary Intervention in Acute Coronary Syndromes: A Meta-Analysis

G. Stone, Hyo‐Soo Kim, Byeong‐Keuk Kim, 2022, Circulation. Cardiovascular interventions.

The CYP2C19*17 allele is associated with better platelet response to clopidogrel in patients admitted for non‐ST acute coronary syndrome

J. Hulot, T. Cuisset, M. Alessi, 2009, Journal of thrombosis and haemostasis : JTH.

Genetic and platelet function testing of antiplatelet therapy for percutaneous coronary intervention: the ARCTIC-GENE study

E. Vicaut, E. Belle, G. Montalescot, 2015, European Journal of Clinical Pharmacology.

Defining Strategies of Modulation of Antiplatelet Therapy in Patients With Coronary Artery Disease: A Consensus Document from the Academic Research Consortium

Deepak L. Bhatt, P. Serruys, M. Krucoff, 2023, Circulation.

Interference of Drug-Eluting Stents With Endothelium-Dependent Coronary Vasomotion: Evidence for Device-Specific Responses

O. Muller, W. Wijns, G. Sarno, 2008, Circulation. Cardiovascular interventions.

In vitro and in vivo studies on thermistor‐based intracoronary temperature measurements: Effect of pressure and flow

F. N. van de Vosse, Giovanna Sarno, Christophe Beauloye, 2009, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

CD11b+ leukocyte microparticles are associated with high‐risk angiographic lesions and recurrent cardiovascular events in acute coronary syndromes

P. Morange, T. Cuisset, J. Bonnet, 2011, Journal of thrombosis and haemostasis : JTH.

The SYNERGY II Everolimus elutiNg stent In patients Older than 75 years undergoing coronary Revascularisation associated with a short dual antiplatelet therapy (SENIOR) trial: rationale and design of a large-scale randomised multicentre study.

O. Hanon, I. Durand-zaleski, P. Sinnaeve, 2017, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Direct stenting for stable angina pectoris is associated with reduced periprocedural microcirculatory injury compared with stenting after pre-dilation.

W. Wijns, G. Sarno, E. Barbato, 2008, Journal of the American College of Cardiology.

074 Comparison of rosuvastatin and atorvastatin on clopidogrel response and lipidic and inflammatory parameters after coronary stenting for acute coronary syndrome

P. Morange, T. Cuisset, J. Bonnet, 2012 .

Reply: De-Escalation of the P2Y12 Inhibitor After Acute Coronary Syndromes According to On-Treatment Platelet Reactivity: A Promising Step of Enormous Magnitude That Should Be Explored.

T. Cuisset, J. Bonnet, P. Deharo, 2018, JACC. Cardiovascular interventions.

Coronary Vasomotion One Year after Drug-Eluting Stent Implantation: Comparison of Everolimus-Eluting and Paclitaxel-Eluting Coronary Stents

P. Vardas, C. Vassanelli, W. Wijns, 2014, Journal of Cardiovascular Translational Research.

Adenosine plasma level correlates with homocysteine and uric acid concentrations in patients with coronary artery disease.

R. Guieu, T. Cuisset, P. Deharo, 2016, Canadian journal of physiology and pharmacology.

Outcomes in nonagenarians undergoing transcatheter aortic valve implantation (TAVI): data from a nationwide analysis.

L. Fauchier, T. Cuisset, P. Deharo, 2019, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Safety and effectiveness of the association ezetimibe-statin (E-S) versus high dose rosuvastatin after acute coronary syndrome: the SAFE-ES study.

P. Morange, M. Alessi, G. Bonnet, 2014, Annales de cardiologie et d'angeiologie.

2013 ESC guidelines on the management of stable coronary artery disease. The Task Force on the management of stable coronary artery disease of the European Society of Cardiology

S. Achenbach, B. Gersh, M. Pfisterer, 2014 .

Platelet P2Y12 Inhibitor Monotherapy after Percutaneous Coronary Intervention: An Emerging Option for Antiplatelet Therapy De-escalation

K. Huber, J. Collet, F. Verheugt, 2022, Thrombosis and Haemostasis.

Cost-Effectiveness of Drug-Eluting Stents in Elderly Patients With Coronary Artery Disease: The SENIOR Trial

S. Cook, I. Durand-zaleski, P. Sinnaeve, 2019, Value in Health.

Net clinical benefit of dual antiplatelet therapy in elderly patients with acute coronary syndrome: A systematic review and meta-analysis.

S. Kohsaka, T. Kuno, Tomohiro Fujisaki, 2023, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of

B. Lewis, J. Mehilli, S. Windecker, 2016 .

Non-adherence to aspirin in patients undergoing coronary stenting: negative impact of comorbid conditions and implications for clinical management.

W. Cohen, P. Carrieri, T. Cuisset, 2011, Archives of cardiovascular diseases.

2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes The Task Force for the diagnosis and management of chronic coronary syndromes of the European Society of Cardiology (ESC)

Jeroen J. Bax, S. Achenbach, B. Gersh, 2020, Russian Journal of Cardiology.

Platelet function monitoring in elderly patients on prasugrel after stenting for an acute coronary syndrome: design of the randomized antarctic study.

E. Vicaut, G. Montalescot, J. Collet, 2014, American heart journal.

Lack of effect of chronic kidney disease on clopidogrel response with high loading and maintenance doses of clopidogrel after Acute Coronary Syndrome.

P. Morange, M. Alessi, T. Cuisset, 2010, Thrombosis research.

Recent advances in the pharmacogenetics of clopidogrel

P. Morange, M. Alessi, T. Cuisset, 2011, Human Genetics.